Bioengineering | |||
| Session 173 - Building Drug Delivery into Tissue Engineering | |||
| Traditionally, tissue engineering has involved the development of new materials that encourage cell infiltration and proliferation. New opportunities exist to also confer therapeutic properties on engineered tissues by the controlled, targeted release of drugs. Applications of drug delivery systems in tissue engineering include wound healing, antinflammatory treatment near implants, and antitumor therapies. | |||
| Chair: | Tao L. Lowe | ||
| CoChair: | Agnes Ostafin | ||
| 173a | DNA Loaded Multiple Channel Bridges for Spinal Cord Regeneration Laura De Laporte, Yang Yang, Marina L. Zelivyanskaya, Aileen J. Anderson, Lonnie D. Shea | ||
| 173b | Microfluidic Scaffolds for Tissue Engineering Nak Won Choi, Mario Cabodi, Abraham D. Stroock, Omotunde Babalola, Lawrence J. Bonassar | ||
| 173c | Enhancing Nanoparticle Penetration in the Brain by Convection Enhanced Delivery and Enzymatic Degradation of the Extracellular Matrix Keith B. Neeves, Andrew Sawyer, Conor P. Foley, William L. Olbricht, W. Mark Saltzman | ||
| 173d | Calcium Phosphate Shell Delivery System for Bone Repair Agnes Ostafin, Stephanie Schmidt | ||
| Break | |||
| 173e | Osteoblast Response to Amorphous Calcium Phosphate in Vitro Jenni R. Popp, Brian J. Love, Aaron S. Goldstein | ||
| 173f | The Hydroxyapatite Affinity and Binding Kinetics of Peptides Modified with Bisphosphonates, Poly(Aspartic Acid), and Poly(Glutamic Acid) Matthew B. Murphy, Antonios G. Mikos | ||
| 173g | Affinity Hydrogels: Tailored Protein Delivery from Permissive Tissue Engineering Matrices Andrew T. Metters, Chien Chi Lin | ||
See more of Food, Pharmaceutical & Bioengineering Division